The stock had been in a consolidation phase for the past four years, with the 750–760 zone acting as a strong resistance on two prior occasions. This key hurdle has now been decisively breached, confirming a long-term breakout. Volume analysis supports the move, as strong buying interest is evident during upswings, while downswings are accompanied … Read more
Apr 12, 2024, 03:23:27 PM IST Smallcap funds saw outflows in March for the first time in 31 months, suggesting a possibility of lump sum withdrawals by investors amidst Sebi and fund houses’ efforts to curb inflows. Amid this backdrop, these stocks managed to lure investors and were among the top buys from smallcap space. … Read more
MUMBAI: Undoubtedly, the current financial year has been a remarkable one for the little ninjas of Dalal Street – smallcap stocks – as we saw as many as 181 of them turning multibaggers. What’s worth noting is that more than 100 of these smallcap stocks went through a bad phase in the preceding financial year. … Read more
While the benchmarks Sensex and Nifty 50 clocked losses for the fourth straight week, the broader market also lost some of its momentum as was visible in the stock performance. In the week gone by, 55 smallcap stocks gave double-digit positive weekly returns, as compared to 75 stocks a week ago. In the BSE 500 … Read more
After losses in the last week, the short-term trajectory of domestic equities is seen as weak, and investors may sit on the fence looking for fresh cues, as the earnings season draws to a close. Therefore, rangebound trade could be seen in indices in the truncated week ahead. The stock markets are closed on Tuesday … Read more
Mumbai: Wockhardt Hospital, Mumbai Central has entered into a partnership with HaystackAnalytics to embark into the realm of precision genomics with the help of whole exome sequencing. By partnering with HaystackAnalytics, Wockhardt Hospital – Mumbai Central aims to leverage the power of genomics to enhance patient care and improve health outcomes. The Genetic Health Plan … Read more
The December quarter earnings were a mixed big, but an analysis of the bottomline performance of the companies showed that as many as 41 of them reported a loss for the fourth straight quarter. The analysis by ETMarkets was done on companies with a minimum market capitalisation of Rs 500 crore. The new-age technology companies, … Read more
Wockhardt will manufacture and supply to Enso up to 620 million doses of the Sputnik V vaccine and the Sputnik Light vaccine, Wockhardt said. Pharmaceutical major Wockhardt will be producing Sputnik V vaccines in India. The company said on Friday it has partnered with the Russian Direct Investment Fund (RDIF) to produce Sputnik V and … Read more
Mumbai: Drug maker Wockhardt jumped 10 per cent in Thursday’s session in heavy volume trade, extending the recent rally in stock. The trigger for the momentum in the stock could not be ascertained but it is a low free-float stock. Such stocks typically witness sharp volatile moves, depending on developments. At 2:50 pm, the stock … Read more
New Delhi: Shares of Wockhardt surged 10 per cent in Tuesday’s trade after the biotechnology major said it has entered into an agreement with the UK government to fill-finish Covid-19 vaccines. The manufacturing will be undertaken at CP Pharmaceuticals, a subsidiary of Wockhardt based in Wrexham, North Wales, the drugmaker said in a BSE filing. … Read more